{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:33Z","timestamp":1793332473154,"version":"4.5.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016175","name":"Chulabhorn Royal Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pulmonary surfactant (PS) is one of the main treatment for neonates with respiratory distress syndrome (RDS). Budesonide has recently been studied as an additional treatment in such cases, but there is limited evidence supporting this. This study was implemented to determine the efficacy of PS combined with budesonide in premature infants. To achieve this, we conducted a systematic review and meta-analysis of randomized controlled trials by searching PubMed, Scopus, Embase, and the Cochrane Library from inception until July 12, 2024. We utilized a random-effects model to calculate the risk ratio and mean differences (MDs) with 95% confidence intervals (CIs) for the clinical outcomes of PS with budesonide versus PS alone. We used the GRADE approach to assess the quality of the evidence. We included 26 randomized controlled trials with a total of 2701 patients in the analysis. Treatments of PS with budesonide and PS alone were compared in all trials. PS with budesonide reduced bronchopulmonary dysplasia (BPD) incidence (risk ratio, 0.61; 95% CI, 0.51, 0.73), duration of mechanical or invasive mechanical ventilation (MD, \u22122.21 days; 95% CI, \u22122.72, \u22121.71), duration requiring oxygen (MD, \u22125.86 days; 95% CI, \u22128.44, \u22123.29), and hospitalization time (MD, \u22125.61 days; 95% CI, \u22128.65, \u22122.56). These results were based on low to very low evidence certainty. Only moderate-to-severe BPD or severe BPD showed a significant reduction when PS was used in conjunction with budesonide, a finding supported by moderate evidence certainty. Our study showed that the administration of PS with budesonide significantly improved respiratory outcomes, including the incidence of BPD, duration of mechanical or invasive mechanical ventilation, duration requiring oxygen, and hospitalization time in preterm infants, without short-term adverse drug events. However, the evidence certainty was mostly low to very low.<\/jats:p>","DOI":"10.1371\/journal.pone.0312561","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:37:42Z","timestamp":1736447862000},"page":"e0312561","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of pulmonary surfactant with budesonide in premature infants: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Nanthida","family":"Phattraprayoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-5367","authenticated-orcid":true,"given":"Mingkwan","family":"Na Takuathung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"5","key":"pone.0312561.ref001","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamapediatrics.2021.6619","article-title":"Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses","volume":"176","author":"T Abiramalatha","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"4","key":"pone.0312561.ref002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1700827","article-title":"Ventilation in Extremely Preterm Infants and Respiratory Function at 8 Years","volume":"377","author":"LW Doyle","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0312561.ref003","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.siny.2009.08.004","article-title":"Long-term outcomes of bronchopulmonary dysplasia","volume":"14","author":"LW Doyle","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6789","key":"pone.0312561.ref004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(53)91451-2","article-title":"Hyaline membrane in the neonatal lung","volume":"265","author":"AE Claireaux","year":"1953","journal-title":"Lancet"},{"issue":"Suppl 1","key":"pone.0312561.ref005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.pedneo.2020.11.005","article-title":"Respiratory distress syndrome in preterm neonates in the era of precision medicine: A modern critical care-based approach","volume":"62","author":"D. De Luca","year":"2021","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"pone.0312561.ref006","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/pan.14365","article-title":"Bronchopulmonary dysplasia","volume":"32","author":"AR Schmidt","year":"2022","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"pone.0312561.ref007","first-page":"5","article-title":"Pulmonary surfactants and their role in pathophysiology of lung disorders","volume":"51","author":"A Akella","year":"2013","journal-title":"Indian J Exp Biol"},{"issue":"4","key":"pone.0312561.ref008","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000499361","article-title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome\u20142019 Update","volume":"115","author":"DG Sweet","year":"2019","journal-title":"Neonatology"},{"issue":"2","key":"pone.0312561.ref009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00408-018-0084-z","article-title":"Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment","volume":"196","author":"JS Hwang","year":"2018","journal-title":"Lung"},{"issue":"11","key":"pone.0312561.ref010","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1542\/neo.24-11-e691","article-title":"Postnatal Corticosteroids To Prevent Bronchopulmonary Dysplasia","volume":"24","author":"EA Jensen","year":"2023","journal-title":"Neoreviews"},{"key":"pone.0312561.ref011","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/IJGM.S158184","article-title":"Evaluating the use of corticosteroids in preventing and treating bronchopulmonary dysplasia in preterm neonates","volume":"11","author":"O Olaloko","year":"2018","journal-title":"Int J Gen Med"},{"issue":"10","key":"pone.0312561.ref012","first-page":"Cd002058","article-title":"Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates","volume":"10","author":"SS Shah","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pone.0312561.ref013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/peds.2004-2843","article-title":"Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial","volume":"117","author":"LW Doyle","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"pone.0312561.ref014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000515950","article-title":"Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia","volume":"118","author":"LW Doyle","year":"2021","journal-title":"Neonatology"},{"issue":"1","key":"pone.0312561.ref015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal Administration of Budesonide\/Surfactant to Prevent Bronchopulmonary Dysplasia","volume":"193","author":"TF Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0312561.ref016","doi-asserted-by":"crossref","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: A pilot study","volume":"121","author":"TF Yeh","year":"2008","journal-title":"Pediatr"},{"issue":"5","key":"pone.0312561.ref017","first-page":"400","article-title":"Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: A comparative analysis","volume":"18","author":"H Ke","year":"2016","journal-title":"Chin J Contemp Pediatr"},{"issue":"4","key":"pone.0312561.ref018","first-page":"1","article-title":"Intratracheal Administration of Budesonide-instilled Surfactant for Prevention of Bronchopulmonary Dysplasia: A Randomized Controlled Clinical Trial","volume":"14","author":"AM Armanian","year":"2023","journal-title":"Iranian Journal of Neonatology"},{"issue":"10","key":"pone.0312561.ref019","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1034\/j.1398-9995.2001.00100.x","article-title":"Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device","volume":"56","author":"JC Dubus","year":"2001","journal-title":"Allergy"},{"issue":"4","key":"pone.0312561.ref020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"G Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"7650","key":"pone.0312561.ref021","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"pone.0312561.ref022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias)","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"pone.0312561.ref023","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence-inconsistency","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"pone.0312561.ref024","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence-indirectness","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"pone.0312561.ref025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence-imprecision","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"pone.0312561.ref026","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence-publication bias","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"pone.0312561.ref027","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpeds.2009.10.049","article-title":"A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants","volume":"156","author":"HT Kuo","year":"2010","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0312561.ref028","first-page":"434","article-title":"Study on combining budesonide suspension, pulmonary surfactant Curosurf and nasal continuous positive airway pressure in treatment of respiratory distress syndrome of premature","volume":"17","author":"J Wan","year":"2010","journal-title":"Pharmaceutical Biotechnology"},{"issue":"2","key":"pone.0312561.ref029","first-page":"137","article-title":"Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants","volume":"19","author":"J Pan","year":"2017","journal-title":"Chin J Contemp Pediatr"},{"issue":"3","key":"pone.0312561.ref030","first-page":"25","article-title":"Aerosol inhalation of budesonide and pulmonary surfactant for the prevent bronchopulmonary dysplasia","volume":"24","author":"Y Cao","year":"2018","journal-title":"J Pediatr Pharm"},{"issue":"1","key":"pone.0312561.ref031","first-page":"91","article-title":"Efficacy of intracheal of budesonide using surfactant as a vehicle to treatment respiratory distress syndrome of preterm infants","volume":"46","author":"L Deng","year":"2018","journal-title":"Med Sci J Cent South China"},{"issue":"5","key":"pone.0312561.ref032","first-page":"796","article-title":"Observation on curative effect of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia in premature infants","volume":"20","author":"L Luo","year":"2018","journal-title":"Zhejiang Clin Med"},{"key":"pone.0312561.ref033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijpvm.IJPVM_336_16","article-title":"The Effect of Inhaled Budesonide on the Prevention of Chronic Lung Disease in Premature Neonates with Respiratory Distress Syndrome","volume":"9","author":"A Sadeghnia","year":"2018","journal-title":"Int J Prev Med"},{"issue":"11","key":"pone.0312561.ref034","first-page":"1243","article-title":"Effect of budesonide inhalation combined with pulmonary surfactant on newborns with RDS","volume":"46","author":"Y Wang","year":"2018","journal-title":"Mod Med J"},{"issue":"04","key":"pone.0312561.ref035","first-page":"416","article-title":"Effects of different forms of budesonide combined with pulmonary surfactant in improving blood gas indicators and bronchopulmonary dysplasia in children with neonatal respiratory distress syndrome","volume":"11","author":"J Yu","year":"2018","journal-title":"Chin J Lung Dis"},{"issue":"24","key":"pone.0312561.ref036","first-page":"11032","article-title":"Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway","volume":"23","author":"FL Du","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"pone.0312561.ref037","first-page":"154","article-title":"Influence of combined drug therapy by intratracheal infusion on clinical prognosis of premature infants with severe RDS","volume":"42","author":"L Ping","year":"2019","journal-title":"Chin J Postgrad Med"},{"key":"pone.0312561.ref038","first-page":"61","article-title":"The clinical study of budesonide combined with pulmonary surfactant to prevent bronchopulmonary dysplasia in premature infants","volume":"6","author":"J Su","year":"2019","journal-title":"Int J of Pediatr"},{"key":"pone.0312561.ref039","first-page":"2121","article-title":"Effect of budesonide suspension oxygenation atomization inhalation on prevention and treatment of bronchopulmonary dysplasia in premature infants","volume":"19","author":"Y Wang","year":"2019","journal-title":"J Clin Exp Med"},{"issue":"11","key":"pone.0312561.ref040","first-page":"27","article-title":"Effects of budesonide combined with pulmonary surfactant on short-term efficacy, blood oxygen index, and risk of bronchopulmonary dysplasia in preterm infants with severe respiratory distress syndrome","volume":"25","author":"X Zhou","year":"2019","journal-title":"J Pediatr Pharm"},{"issue":"3","key":"pone.0312561.ref041","first-page":"252","article-title":"Effect of budesonide on pulmonary surfactant in treating neonatal respiratory distress syndrome","volume":"27","author":"A Chen","year":"2020","journal-title":"Pharm Biotechnol"},{"issue":"2329524","key":"pone.0312561.ref042","first-page":"6","article-title":"Evaluation of the Efficacy of Budesonide Combined with Pulmonary Surfactants on the Neonatal Respiratory Distress Syndrome by Pulmonary Ultrasonography","volume":"2021","author":"Z. Chuanlong","year":"2021","journal-title":"Sci Program"},{"key":"pone.0312561.ref043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jrms.JRMS_106_19","article-title":"The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia","volume":"26","author":"MM Gharehbaghi","year":"2021","journal-title":"J Res Med Sci"},{"issue":"2","key":"pone.0312561.ref044","first-page":"33","article-title":"Pulmonary surfactant in combination with intratracheal budesonide instillation for treatment of respiratory distress syndrome in preterm infants: A randomized controlled trial","volume":"36","author":"B Yang","year":"2021","journal-title":"Chin J Neonatology"},{"issue":"5","key":"pone.0312561.ref045","first-page":"4949","article-title":"Efficacy of budesonide in the prevention and treatment of bronchopulmonary dysplasia in premature infants and its effect on pulmonary function","volume":"13","author":"Y Yao","year":"2021","journal-title":"Am J Transl Res"},{"issue":"16","key":"pone.0312561.ref046","first-page":"102","article-title":"Effect of calf pulmonary surfactant for injection combined with budesonide on prevention and treatment of neonatal bronchopulmonary dysplasia","volume":"48","author":"J Zheng","year":"2021","journal-title":"Chin J Pract Med"},{"issue":"1","key":"pone.0312561.ref047","first-page":"78","article-title":"Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: A prospective randomized controlled trial","volume":"24","author":"M Liu","year":"2022","journal-title":"Chin J Contemp Pediatr"},{"issue":"4","key":"pone.0312561.ref048","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/jcn.jcn_52_23","article-title":"Budesonide and surfactant combination for treatment of respiratory distress syndrome in preterm neonates and evaluation outcomes","volume":"12","author":"FB Safa","year":"2023","journal-title":"J Clin Neonatol"},{"issue":"1","key":"pone.0312561.ref049","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12887-024-04736-9","article-title":"The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial","volume":"24","author":"A Marzban","year":"2024","journal-title":"BMC Pediatr"},{"issue":"8","key":"pone.0312561.ref050","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00431-019-03398-5","article-title":"Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis","volume":"178","author":"IP Morris","year":"2019","journal-title":"Eur J Pediatr"},{"key":"pone.0312561.ref051","doi-asserted-by":"crossref","first-page":"106050","DOI":"10.1016\/j.earlhumdev.2024.106050","article-title":"The use of two or more courses of low-dose systemic dexamethasone to extubate ventilator-dependent preterm neonates may be associated with a higher prevalence of cerebral palsy at two years of corrected age","volume":"194","author":"G Rocha","year":"2024","journal-title":"Early Hum Dev"},{"issue":"3","key":"pone.0312561.ref052","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.83.3.F177","article-title":"Early postnatal dexamethasone treatment and increased incidence of cerebral palsy","volume":"83","author":"ES Shinwell","year":"2000","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"pone.0312561.ref053","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ppul.25759","article-title":"Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis","volume":"57","author":"W Tang","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"pone.0312561.ref054","doi-asserted-by":"crossref","first-page":"526","DOI":"10.21037\/tp-22-8","article-title":"A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome","volume":"11","author":"Z Yi","year":"2022","journal-title":"Transl Pediatr"},{"key":"pone.0312561.ref055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13052-015-0135-5","article-title":"Prognosis of psychomotor and mental development in premature infants by early cranial ultrasound","volume":"41","author":"Y Duan","year":"2015","journal-title":"Ital J Pediatr"},{"key":"pone.0312561.ref056","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fped.2020.00485","article-title":"Prediction of Delayed Neurodevelopment in Infants Using Brainstem Auditory Evoked Potentials and the Bayley II scales","volume":"8","author":"X Wang","year":"2020","journal-title":"Front Pediatr"},{"issue":"12","key":"pone.0312561.ref057","doi-asserted-by":"crossref","first-page":"e22414","DOI":"10.1016\/j.heliyon.2023.e22414","article-title":"The relationship between late (\u2265 7 days) systemic dexamethasone and functional network connectivity in very preterm infants","volume":"9","author":"W Jia","year":"2023","journal-title":"Heliyon"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:37:58Z","timestamp":1736447878000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312561"}},"subtitle":[],"editor":[{"given":"Stefan","family":"Grosek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312561","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}